Related Experiment Video

Updated: Sep 26, 2026

Methods for the Modulation and Analysis of NF-κB-dependent Adult Neurogenesis
14:58

Methods for the Modulation and Analysis of NF-κB-dependent Adult Neurogenesis

Published on: February 13, 2014

Glioma cell-associated sustained activation of the transcription factor, nuclear factor-kappa B, was inhibited by

Pedro Cuevas1, Diana Díaz-González, Manuel Dujovny

  • 1Departamento de Investigacion, Hospital Universitario Ramon y Cajal, Universidad de Alcala de Henares, 28034 Madrid, Spain. pedro.cuevas@hrc.es

Neurological Research
|May 13, 2003
PubMed

Insights

Neomycin significantly reduces nuclear factor-Kappa B (NF-kappa B) activation in glioma cells, suggesting its potential for treating invasive brain tumors by inhibiting growth and promoting apoptosis.

Area of Science:

  • Oncology
  • Molecular Biology
  • Neuroscience

Background:

  • Malignant glioma is a highly invasive brain tumor.
  • Nuclear factor-Kappa B (NF-kappa B) is implicated in tumor growth, invasion, and apoptosis suppression.
  • NF-kappa B signaling is a key target for cancer therapeutics.

Purpose of the Study:

  • To investigate the effect of neomycin on NF-kappa B activity in glioma cell cultures.
  • To determine if neomycin can modulate key pathways involved in glioma progression.
  • To explore neomycin as a potential therapeutic agent for malignant gliomas.

Main Methods:

  • Glioma cell cultures were treated with neomycin.
  • Immunocytochemical analysis was performed using the NF-kappa Bp65 antibody.
  • Changes in NF-kappa B activation were quantified.

Main Results:

  • Neomycin treatment significantly decreased NF-kappa B activation in glioma cells.
  • The effect was observed after a 30-minute incubation period.
  • Neomycin demonstrates inhibitory effects on a critical oncogenic pathway.

Conclusions:

  • Neomycin effectively inhibits NF-kappa B activation in glioma cells.
  • These findings support a role for neomycin in controlling glioma invasion, apoptosis, and growth.
  • Neomycin warrants further investigation in clinical trials for glioma treatment.

More Related Videos

Molecular Modulation by Lentivirus-Delivered Specific shRNAs in Endoplasmic Reticulum Stressed Neurons10:50

Molecular Modulation by Lentivirus-Delivered Specific shRNAs in Endoplasmic Reticulum Stressed Neurons

Published on: April 24, 2021

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
Regulation of Nuclear Protein Sorting01:45

Regulation of Nuclear Protein Sorting

Nuclear protein sorting regulates nucleus composition and gene expression, crucial for determining the fate of a eukaryotic cell. Hence, the entry and exit of molecules across the nuclear envelope is a tightly controlled process. Nuclear protein sorting can be inhibited by one of the following ways: 1) masking cargo signal sequences, 2) modifying the nuclear receptor's affinity for cargo, 3) controlling the nuclear pore size, 4) retaining the cargo during its transit to the cytosol or the...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...